Prion formation correlates with activation of translation-regulating protein 4E-BP and neuronal transcription factor Elk1
- PMID: 23742760
- DOI: 10.1016/j.nbd.2013.05.014
Prion formation correlates with activation of translation-regulating protein 4E-BP and neuronal transcription factor Elk1
Abstract
Cellular mechanisms play a role in conversion of the normal prion protein PrP(C) to the disease-associated protein PrP(Sc). The cells provide not only PrP(C), but also still largely undefined factors required for efficient prion replication. Previously, we have observed that interference with ERK and p38-JNK MAP kinase pathways has opposing effects on the formation of prions indicating that the process is regulated by a balance in intracellualar signaling pathways. In order to obtain a "flow-chart" of such pathways, we here studied the activation of MEK/ERK and mTORC1 downstream targets in relation to PrP(Sc) accumulation in GT1-1 cells infected with the RML or 22L prion strains. We show that inhibition of mTORC1 with rapamycin causes a reduction of PrP(Sc) accumulation at similar low levels as seen when the interaction between the translation initiation factors eIF4E and eIF4G downstream mTORC1 is inhibited using 4EGI-1. No effect is seen following the inhibition of molecules (S6K1 and Mnk1) that links MEK/ERK signaling to mTORC1-mediated control of translation. Instead, stimulation (high [KCl] or [serum]) or inhibition (MEK-inhibitor) of prion formation is associated with increased or decreased phosphorylation of the neuronal transcription factor Elk1, respectively. This study shows that prion formation can be modulated by translational initiating factors, and suggests that MEK/ERK signaling plays a role in the conversion of PrP(C) to PrP(Sc) via an Elk1-mediated transcriptional control. Altogether, our studies indicate that prion protein conversion is under the control of intracellular signals, which hypothetically, under certain conditions may elicit irreversible responses leading to progressive neurodegenerative diseases.
Keywords: 4E-BP; BDNF; BrdU; CGP 57380; DMSO; ERK; GT1-1 cells; Infections; Intracellular signaling; MAP; MAP kinase-interacting kinases; MEK; MEK-inhibitor (1,4-diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto) butadiene ethanolate); Mnk1-inhibitor N3-(4-fluorophenyl)-1h-pyrazolo[3,4-d]pyrimidine-3,4-diamine; Mnk1/2; Nervous system; Neurodegenerative diseases; PF-4708671; PrP(C); PrP(Sc); Prions; S6K1; S6K1-inhibitor 2-((4-(5-ethylpyrimidin-4-yl)piperazin-1-yl)methyl)-5-(trifluoromethyl)-1H-benzo[d]imidazole; S6rp; TSC; U0126; brain-derived neurotrophic factor; bromodeoxiuridine; dimethyl sulfoxide; disease-associated prion protein; eIF4E; eukaryotic initiation factor 4E; eukaryotic initiation factor 4E binding protein; extracellular signal-regulated kinase; immortalized hypothalamic gonadotropin-releasing hormone neurons; leupeptin; leupeptin hydrochloride; mTORC1; mammalian target of rapamycin complex 1; mitogen-activated protein; mitogen-activated protein kinase kinase; normal cellular prion protein; p70 ribosomal S6 Kinase 1; ribosomal protein S6; tuberous sclerosis complex.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Opposing effects of ERK and p38-JNK MAP kinase pathways on formation of prions in GT1-1 cells.FASEB J. 2009 Feb;23(2):613-22. doi: 10.1096/fj.08-115360. Epub 2008 Sep 29. FASEB J. 2009. PMID: 18824519
-
Intracerebroventricular administration of ouabain, a Na/K-ATPase inhibitor, activates mTOR signal pathways and protein translation in the rat frontal cortex.Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:73-82. doi: 10.1016/j.pnpbp.2013.04.018. Epub 2013 May 2. Prog Neuropsychopharmacol Biol Psychiatry. 2013. PMID: 23643758
-
Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability.Biochem J. 2003 Jun 1;372(Pt 2):555-66. doi: 10.1042/BJ20021266. Biochem J. 2003. PMID: 12611592 Free PMC article.
-
Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis.Eur Respir Rev. 2023 Sep 27;32(169):230100. doi: 10.1183/16000617.0100-2023. Print 2023 Sep 30. Eur Respir Rev. 2023. PMID: 37758276 Free PMC article. Review.
-
Relationships between cobalamin, epidermal growth factor, and normal prions in the myelin maintenance of central nervous system.Int J Biochem Cell Biol. 2014 Oct;55:232-41. doi: 10.1016/j.biocel.2014.09.011. Epub 2014 Sep 17. Int J Biochem Cell Biol. 2014. PMID: 25239885 Review.
Cited by
-
Development of kinomic analyses to identify dysregulated signaling pathways in cells expressing cytoplasmic PrP.Virol J. 2014 Oct 3;11:175. doi: 10.1186/1743-422X-11-175. Virol J. 2014. PMID: 25280966 Free PMC article.
-
Strain-Dependent Effect of Macroautophagy on Abnormally Folded Prion Protein Degradation in Infected Neuronal Cells.PLoS One. 2015 Sep 14;10(9):e0137958. doi: 10.1371/journal.pone.0137958. eCollection 2015. PLoS One. 2015. PMID: 26368533 Free PMC article.
-
NMDA Receptor and L-Type Calcium Channel Modulate Prion Formation.Cell Mol Neurobiol. 2021 Jan;41(1):191-198. doi: 10.1007/s10571-020-00834-1. Epub 2020 Apr 1. Cell Mol Neurobiol. 2021. PMID: 32239389 Free PMC article.
-
Molecular mechanism of the dual activity of 4EGI-1: Dissociating eIF4G from eIF4E but stabilizing the binding of unphosphorylated 4E-BP1.Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):E4036-45. doi: 10.1073/pnas.1512118112. Epub 2015 Jul 13. Proc Natl Acad Sci U S A. 2015. PMID: 26170285 Free PMC article.
-
Second messengers mediating the expression of neuroplasticity in a model of chronic pain in the rat.J Pain. 2014 Mar;15(3):312-20. doi: 10.1016/j.jpain.2013.12.005. Epub 2014 Jan 7. J Pain. 2014. PMID: 24407022 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous